General Information of the Compound
Compound ID |
CP0373098
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
4-butyl-N-pyridin-3-ylbenzamide
Show/Hide
|
||||||||||||||||||
Synonyms |
(4-butylphenyl)-N-(3-pyridyl)carboxamide
4-butyl-N-(pyridin-3-yl)benzamide
4-butyl-N-pyridin-3-ylbenzamide
AC1N7X0I
AKOS001583267
BDBM50376254
CHEMBL259396
MCULE-4107696507
MolPort-003-720-572
Oprea1_505737
SR-01000396349
ST50859128
STK493059
ZINC3899411
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C16H18N2O
|
||||||||||||||||||
Molecular Weight |
254.333
|
||||||||||||||||||
Canonical SMILES |
CCCCc1ccc(cc1)C(=O)Nc1cccnc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C16H18N2O/c1-2-3-5-13-7-9-14(10-8-13)16(19)18-15-6-4-11-17-12-15/h4,6-12H,2-3,5H2,1H3,(H,18,19)
Show/Hide
|
||||||||||||||||||
InChIKey |
KDHOWTVYQKITMO-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound